• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ARMADA 14 PTA CATHETER; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ARMADA 14 PTA CATHETER; PERIPHERAL DILATATION CATHETER Back to Search Results
Catalog Number A2030-040
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 01/04/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Evaluation summary: visual and functional inspections were performed on the returned device.The reported balloon rupture was confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported balloon rupture appears to be related to circumstances of the procedure.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion in the non-tortuous, heavily calcified anterior tibial artery in the right leg.A 3.0 x 40 mm armada 14 percutaneous transluminal angioplasty (pta) catheter was selected for the procedure.There were no issues noted with the pta catheter during unpacking, inspection and preparation.The pta catheter was advanced with no resistance felt to the lesion and crossed.Upon the first inflation to approximately 6 - 8 atmospheres the balloon ruptured.The pta catheter was removed from the anatomy.An unspecified cutting/scoring balloon was used and then a new 3.0 x 40 mm armada 14 pta catheter was used to successfully perform angioplasty on the lesion.There was no reported clinically significant delay in the procedure.There was no reported adverse patient sequela.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA 14 PTA CATHETER
Common Device Name
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key6281803
Report Number2024168-2017-00720
Device Sequence Number16279513
Product Code LIT
UDI-Device Identifier08717648156076
UDI-Public(01)08717648156076(17)190228(10)5091041
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K102705
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date (Section B) 01/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2019
Device Catalogue NumberA2030-040
Device Lot Number5091041
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/12/2017
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/04/2017
Initial Report FDA Received Date01/26/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age63 YR
-
-